Single nucleotide polymorphisms in the interleukin-6 gene associated with blood pressure and atherosclerosis in a Japanese general population

Hypertension Research

Volumn 28, Issue 1, 2005, Pages 35-41

  Tanaka, Chihiro ^a,b   Mannami, Toshifumi ^a   Kamide, Kei ^a   Takiuchi, Shin ^a   Kokubo, Yoshihiro ^a   Katsuya, Tomohiro ^b   Kawano, Yuhei ^a   Miyata, Toshiyuki ^a   Ogihara, Toshio ^b   Tomoike, Hitonobu ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Blood pressure; Interleukin 6; Japanese general population; Single nucleotide polymorphism

Indexed keywords

ANTIHYPERTENSIVE AGENT; INTERLEUKIN 6;

ADULT; ALLELE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MONITORING; CORRELATION FUNCTION; DISEASE COURSE; FEMALE; FREQUENCY ANALYSIS; GENE FUNCTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; INTRON; JAPAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PROMOTER REGION; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

AGED; ARTERIOSCLEROSIS; BLOOD PRESSURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; INTERLEUKIN-6; INTRONS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 20244366088     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.28.35     Document Type: Article

References (32)

1. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
2. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101 1767-1772.
3. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW: C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978.
4. Chae CU, Lee RT, Rifai N, Ridker PM: Blood pressure and inflammation in apparently healthy men. Hypertension 2001; 38 399-403.
5. Bautista LE: Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence. J Hum Hypertens 2003; 17: 223-230.
6. Keller ET, Wanagat J, Ershler WB: Molecular and cellular biology of interleukin-6 and its receptor. Front Biosci 1996; 1 d340-d357.
7. Nabata T, Morimoto S, Koh E, Shiraishi T, Ogihara T: Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells. Biochem Int 1990; 20: 445-453.
8. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ: The interleukin-6 -174G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001; 22: 2243-2252.
9. Jones KG, Brull DJ, Brown LC, et al: Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001; 103: 2260-2265.
10. Brull DJ, Montgomery HE, Sanders J, et al: Interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001; 21: 1458-1463.
11. Villuendas G, San Millán JL, Sancho J, Escobar-Morreale HF: The -597 G→A and -174 G→C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism. J Clin Endocrinol Metab 2002; 87: 1134-1141.
12. Kitamura A, Hasegawa G, Obayashi H, et al: Interleukin-6 polymorphism (-634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes. Diabet Med 2002; 19: 1000-1005.
13. Terry CF, Loukaci V, Green FR: Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000; 275: 18138-18144.
14. Zhai R, Liu G, Yang C, Huang C, Wu C, Christiani DC: The G to C polymorphism at -174 of the interleukin-6 gene is rare in a Southern Chinese population. Pharmacogenetics 2001; 11: 699-701.
15. Lim CS, Zheng S, Kim YS, et al: The -174 G to C polymorphism of interleukin-6 gene is very rare in Koreans. Cytokine 2002; 19: 52-54.
16. Nakajima T, Ota N, Yoshida H, Watanabe S, Suzuki T, Emi M: Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women. Genes Immun 1999; 1: 115-119.
17. Mannami T, Baba S, Ogata J: Strong and significant relationships between aggregation of major coronary risk factors and the acceleration of carotid atherosclerosis in the general population of a Japanese city: the Suita Study. Arch Intern Med 2000; 160: 2297-2303.
18. Mannami T, Katsuya T, Baba S, et al: Low potentiality of angiotensin-converting enzyme gene insertion/deletion polymorphism as a useful predictive marker for carotid atherogenesis in a large general population of a Japanese city: the Suita study. Stroke 2001; 32 1250-1256.
19. Kokubo Y, Inamoto N, Tomoike H, et al: Association of genetic polymorphisms of sodium-calcium exchanger 1, NCX1, with hypertension in a Japanese general population. Hypertens Res 2004; 27: 697-702.
20. Ono K, Iwanaga Y, Mannami T, et al: Epidemiological evidence of an association between SLC6A2 gene polymorphism and hypertension. Hypertens Res 2003; 26: 685-689.
21. Takiuchi S, Mannami T, Miyata T, et al: Identification of 21 single nucleotide polymorphisms in human hepatocyte growth factor gene and association with blood pressure and carotid atherosclerosis in the Japanese population. Atherosclerosis 2004; 173: 301-307.
22. Kamide K, Tanaka C, Takiuchi S, et al: Six missense mutations of the epithelial sodium channel β- and γ-subunits in Japanese hypertensives. Hypertens Res 2004; 27: 333-338.
23. Antonarakis SE: Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 1998; 11: 1-3.
24. Tanaka C, Kamide K, Takiuchi S, et al: An alternative fast and convenient genotyping method for the screening of angiotensin converting enzyme gene polymorphisms. Hypertens Res 2003; 26: 301-306.
25. Georges JL, Loukaci V, Poirier O, et al: Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. J Mol Med 2001; 79: 300-305.
26. Basso F, Lowe GDO, Rumley A, McMahon AD, Humphries SE: Interleukin-6 -174G>C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol 2002; 22: 599-604.
27. Pola R, Flex A, Gaetani E, Flore R, Serricchio M, Pola P: Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke 2003; 34: 881-885.
28. Fishman D, Faulds G, Jeffery R, et al: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376.
29. Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL: Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 2003; 88: 255-259.
30. Osiri M, McNicholl J, Moreland LW, Bridges SL Jr: A novel single nucleotide polymorphism and five probable haplotypes in the 5′ flanking region of the IL-6 gene in African-Americans. Genes Immun 1999; 1: 166-167.
31. Jenny NS, Tracy RP, Ogg MS, et al: In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 2002; 22: 2066-2071.
32. Jordanides N, Eskdale J, Stuart R, Gallagher G: Allele associations reveal four prominent haplotypes at the human interleukin-6 (IL-6) locus. Genes Immun 2000; 1: 451-455.